Prostate Cancer International is a
non-profit for 2012 as rated by Great NonProfits
Dr. James Eastham is a highly respected and specialized prostate cancer surgeon who works at the Memorial Sloan-Kettering Cancer Center in New York City. In an interview just published on the OncologySTAT web site, he talks about his views on the appropriate application of the PSA test today in assessment of risk for prostate cancer and management of low-risk disease. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: Diagnosis, PSA, risk, screening, testing | Leave a Comment »
Some readers may be interested in reviewing an article that appears in Time magazine this week entitled “Why people stick with cancer screening, even when it causes harm.” The article reviews how our experiences and perceptions may color the way we make our individual decisions about things like screening for breast and prostate cancers.
Filed under: Diagnosis, Risk | Tagged: Diagnosis, risk, screening, testing | 7 Comments »
Earlier, retrospective studies based on Swedish and Danish databases have suggested that men in their 40s with a single PSA level of < 1.0 ng/ml are at low risk for a diagnosis of prostate cancer for up to 30 years after that initial, baseline PSA result. … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: baseline, Diagnosis, PSA, risk, testing | 5 Comments »
Members of the Prostate Cancer Roundtable have received a letter from the Agency for Healthcare Research and Quality (AHRQ) addressing issues raised by the Roundtable members about the draft USPSTF recommendations on use of the PSA test in screening for risk of prostate cancer. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: PSA, risk, screening, testing | 2 Comments »
According to an announcement on the web site of Congressmen Dennis Kucinich late yesterday, HHS Secretary Kathleen Sebelius has agreed to overule the draft recommendation issued by the U.S. Preventive Services Task Force (USPSTF) related to the use of PSA testing as a means to detect prostate cancer. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: Diagnosis, PSA, rfisk, screening, testing | 9 Comments »
A new article published on line late Friday in the Journal of the National Cancer Institute shows “no evidence of a mortality benefit for organized annual screening in the PLCO trial compared with opportunistic screening” for prostate cancer. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: mortality, risk, screening, testing | 11 Comments »
So we might as well acknowledge that the New Year is going to continue where the old year left off when it comes to the issue of testing (“screening”) men for risk of prostate cancer. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: Diagnosis, risk, screening, testing | 1 Comment »
Now here’s a new perspective on the value of widespread prostate cancer screening from one of the founders of Prostate Cancer Awareness Week — Dr. David Crawford of the University of Colorado Health Science Center in Denver, CO (who is also the Chairman of the Prostate Conditions Education Council): … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: elderly, screening, testing, value | 2 Comments »
The value of regular testing of increasingly elderly men and women for risk of cancer is controversial. However, a new paper in the Archives of Internal Medicine has certainly added to our knowledge of just how widespread such testing may be … at least in the USA. … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: elderly, recommendation, screening, testing | 9 Comments »
The October issue of the Canadian Journal of Urology contains an interesting and thorough review of the available data on the value of screening for prostate cancer as seen by a group including urologists, urologic oncologists, medical oncologists, radiation oncologists, and a highly regarded primary care physician. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: mortality, PSA, risk, screening, testing | Leave a Comment »
Larry Axmaker is an 8-year prostate cancer survivor and very happy he had regular PSA screenings! … READ MORE …
Filed under: Diagnosis, Risk | Tagged: recommendation, screening, testing, USPSTF | 1 Comment »
This week’s issue issue of the New England Journal of Medicine includes four perspective articles on the recent draft recommendation about PSA screening issued by the U.S. Preventive Services Task Force (USPSTF). … READ MORE …
Filed under: Diagnosis, Risk | Tagged: PSA, recommendation, screening, testing, USPSTF | 5 Comments »
The following editorial commentary related to the USPSTF recommendation was published on Friday, October 13, 2011 on the UroToday web site and is reproduced here with the permission of UroToday. The commentary was written by Alan Wein, MD, … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: PSA, recommendation, risk, screening, testing, USPSTF | 6 Comments »
The media – over the past few days — has taken every opportunity to “stoke the furore” about the USPSTF’s recommendation that PSA screening (of all men aged 50 to 75 years of age, or thereabouts) is not justified by the available data. … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: PSA, risk, testing, USPSTF | 3 Comments »
The “New” Prostate Cancer InfoLink has replicated below, in its entirety, a media release issued early this morning by the Prostate Cancer Foundation. We believe that this is precisely the correct response to the new USPSTF recommendation: acknowledgement of the realities of the USPSTF’s factually accurate recommendation and the recognition by the USPSTF that PSA testing is not going to go away in the immediate future … nor should it! … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: PCF, Prostate cancer Foundation, screening, testing, USPSTF | 5 Comments »
Search for new and
ongoing trials on the
CTAG PCa web site